COMMUNIQUÉS West-GlobeNewswire

Bionomics Announces Supreme Court of New South Wales Approves Bionomics’ Re-Domiciliation

16/12/2024 - 22:05

ADELAIDE, Australia, and CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) is pleased to announce that the Supreme Court of New South Wales, Australia (“Court”) [...]

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

16/12/2024 - 22:05

BRISBANE, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical [...]

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

16/12/2024 - 22:15

Southlake, TX, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company") , an artificial intelligence (AI)-powered medical technology company focused on transforming [...]

Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update

16/12/2024 - 22:17

FARMINGDALE, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal first quarter ended October 31, 2024. First Quarter [...]

Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024

16/12/2024 - 22:30

Company to host conference call on Tuesday, December 17, at 8:00 a.m. ET SOUTH SAN FRANCISCO, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company [...]

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

16/12/2024 - 22:30

MALVERN, Pa., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”) today announced the granting of inducement awards to new employees as described below. In accordance with NASDAQ Listing [...]

Regeneron Named to Dow Jones Sustainability World Index for Sixth Consecutive Year

16/12/2024 - 22:30

TARRYTOWN, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced its sixth consecutive inclusion in the Dow Jones Sustainability World Index (DJSI World) and fifth [...]

Streamline Health® Reports Fiscal Third Quarter 2024 Financial Results, Accelerates Anticipated Adjusted EBITDA Breakeven Timeline

16/12/2024 - 22:33

Net loss of ($2.5 million) during the third quarter of fiscal 2024 compared to a net loss of ($11.9 million) during the third quarter of fiscal 2023 Company reiterated $15.5 million implemented SaaS ARR adjusted EBITDA [...]

Apu Apustaja and Mental Health America Forge Ground-breaking Partnership to Champion Mental Well-Being in Web3

16/12/2024 - 23:00

Washington, DC, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Emerging blockchain pioneer Apu Apustaja ($APU) has proudly announced a transformative new partnership with Mental Health America (MHA), as of 10th December 2024. In a [...]

Quipt Home Medical Reports Fourth Quarter and Fiscal Year 2024 Financial Results

16/12/2024 - 23:00

Posts Strong Adjusted EBITDA Margin ‎ 1 ‎ for Fiscal Year 2024 and Returns to Positive Sequential Growth in Fiscal Q4 2024 CINCINNATI, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“ Quipt ” or the “ [...]

Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering

16/12/2024 - 23:00

BERKELEY, Calif. and MAINZ, Germany, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. ( NASDAQ:MYNZ ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of [...]

Reviva Announces Proposed Public Offering

16/12/2024 - 23:18

CUPERTINO, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet [...]

Biomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D)

17/12/2024 - 00:15

Tuesday, December 17, 2024 at 8:00 am EST REDWOOD CITY, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and [...]

Harris Dental Unveils Cutting-Edge Technologies to Revolutionize Patient Care

17/12/2024 - 00:18

CAPE COD, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- When it comes to modern healthcare, technology is transforming the field of general dentistry, and Harris Dental is leading the charge in delivering innovative, patient [...]

FOXO TECHNOLOGIES INC. ANNOUNCES THAT STOCKHOLDERS EQUITY IS GREATER THAN $4M, WHICH IS REQUIRED TO MEET THE CONTINUED LISTING REQUIREMENTS OF THE NYSE AMERICAN EXCHANGE

16/12/2024 - 18:32

MINNEAPOLIS, MN, Dec. 16, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”) announces that recent transactions have led to the Company having stockholders equity greater [...]

La Société Alzheimer de l'Ontario souligne une séance législative importante pour les soins liés aux troubles neurocognitifs

16/12/2024 - 18:51

TORONTO, 16 déc. 2024 (GLOBE NEWSWIRE) -- La Société Alzheimer de l’Ontario souhaite saluer le gouvernement pour un mandat législatif important qui a placé un fort accent sur les soins liés aux troubles neurocognitifs. [...]

Alzheimer Society of Ontario Marks an Important Legislative Session for Dementia Care

16/12/2024 - 18:51

TORONTO, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The Alzheimer Society of Ontario would like to congratulate the government on an important legislative term that has placed a strong focus on dementia care. We are encouraged [...]

BioPorto commences process to appoint new Chair of the Board of Directors

16/12/2024 - 18:53

December 16, 2024 Announcement no. 23 BioPorto commences process to appoint new Chair of the Board of Directors COPENHAGEN, DENMARK, December 16, 2024 (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (BioPorto [...]

Vaso Corporation CEO Reflects on a Year of Growth and Innovation in End-of-Year Letter Setting the Tone for a Promising 2025

16/12/2024 - 19:00

Vaso Corporation 137 Commercial Street Plainview, New York 11803 Tel: (516) 997-4600 Fax: (516) 997-2299 NEWS RELEASE PLAINVIEW, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leader [...]